(Q46933034)

26 December 2017

title

Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins (English)

1 reference

26 December 2017

0 references

6

1 reference

26 December 2017

author name string

Scott W Leonard

1

1 reference

26 December 2017

Jacqueline D Joss

2

1 reference

26 December 2017

Debbie J Mustacich

3

1 reference

26 December 2017

David H Blatt

4

1 reference

26 December 2017

Young Sook Lee

5

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

26 December 2017

volume

64

1 reference

26 December 2017

issue

21

1 reference

26 December 2017

page(s)

2257-2266

1 reference

26 December 2017

Vitamin E intake and risk of amyotrophic lateral sclerosis

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Vitamins E and C are safe across a broad range of intakes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Vitamin E, nuclear receptors and xenobiotic metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

α-Tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Vitamin E: function and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Alpha-tocopherol affects the urinary and biliary excretion of 2,7,8-trimethyl-2 (2'-carboxyethyl)-6-hydroxychroman, gamma-tocopherol metabolite, in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Cytochromes P450, drugs, and diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Quantitation of rat liver vitamin E metabolites by LC-MS during high-dose vitamin E administration.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by high-performance liquid chromatography to measure human CYP3A activity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Determination of Creatinine by the Jaffé Reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

{alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Urinary 6?-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Antioxidant supplement use in Women's Health Initiative participants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Brief communication: The prevalence of high intake of vitamin E from the use of supplements among U.S. adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

The Effect of Tocopherol on High-density Lipoprotein Cholesterol: A Clinical Observation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

The failure of alpha-tocopherol supplementation to alter the distribution of lipoprotein cholesterol in normal and hyperlipoproteinemic persons

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Lack of effect of vitamin E on cholesteryl ester transfer and lipoprotein composition in cholesterol-fed rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070041

31 March 2020

Identifiers

DOI

10.2146/AJHP070041

1 reference

26 December 2017

PubMed ID

17959578

1 reference

26 December 2017